ESSA Pharma to Present at Upcoming March Investor Conferences

HOUSTON, Texas and VANCOUVER, Canada, Feb. 25, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at three upcoming virtual investor conferences. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be available for one-on-one meetings.

Presentation Details:

Event: Cowen 41st Annual Health Care Conference

Date: Thursday, March 4, 2021

Event: H.C. Wainwright Annual Global Life Sciences Conference

Date: Tuesday, March 9, 2021

Time (on-demand): 7:00 a.m. ET

Event: Oppenheimer 31st Annual Healthcare Conference

Date: Thursday, March 18, 2021

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the events, the webcasts will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.

SOURCE ESSA Pharma Inc

more press release views with